These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 19768637)

  • 1. Molecular imaging in clinical trials.
    Josephs D; Spicer J; O'Doherty M
    Target Oncol; 2009 Sep; 4(3):151-68. PubMed ID: 19768637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncologic imaging end-points for the assessment of therapy response.
    Serkova NJ; Garg K; Bradshaw-Pierce EL
    Recent Pat Anticancer Drug Discov; 2009 Jan; 4(1):36-53. PubMed ID: 19149687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging Tumor Metastases with Molecular Probes.
    Qiao R; Zhu R; Gao M
    Curr Pharm Des; 2015; 21(42):6260-4. PubMed ID: 26503140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond RECIST: molecular and functional imaging techniques for evaluation of response to targeted therapy.
    Desar IM; van Herpen CM; van Laarhoven HW; Barentsz JO; Oyen WJ; van der Graaf WT
    Cancer Treat Rev; 2009 Jun; 35(4):309-21. PubMed ID: 19136215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From molecular imaging in preclinical/clinical oncology to theranostic applications in targeted tumor therapy.
    Alberti C
    Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1925-33. PubMed ID: 23242718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional imaging of cancer with emphasis on molecular techniques.
    Torigian DA; Huang SS; Houseni M; Alavi A
    CA Cancer J Clin; 2007; 57(4):206-24. PubMed ID: 17626118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imaging tests for the detection of osteomyelitis: a systematic review.
    Llewellyn A; Jones-Diette J; Kraft J; Holton C; Harden M; Simmonds M
    Health Technol Assess; 2019 Oct; 23(61):1-128. PubMed ID: 31670644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of brain imaging instrumentation.
    Abraham T; Feng J
    Semin Nucl Med; 2011 May; 41(3):202-19. PubMed ID: 21440696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular imaging of cancer with copper-64 radiopharmaceuticals and positron emission tomography (PET).
    Shokeen M; Anderson CJ
    Acc Chem Res; 2009 Jul; 42(7):832-41. PubMed ID: 19530674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Imaging of Proteases in Cancer.
    Yang Y; Hong H; Zhang Y; Cai W
    Cancer Growth Metastasis; 2009 Aug; 2():13-27. PubMed ID: 20234801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Technologies for translational imaging using generators in oncology.
    Schechter NR; Yang DJ; Azhdarinia A; Chanda M
    Recent Pat Anticancer Drug Discov; 2007 Nov; 2(3):251-8. PubMed ID: 18221069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive assessment of tumor neovasculature: techniques and clinical applications.
    Perini R; Choe R; Yodh AG; Sehgal C; Divgi CR; Rosen MA
    Cancer Metastasis Rev; 2008 Dec; 27(4):615-30. PubMed ID: 18506398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in medical imaging for cancer diagnosis and treatment.
    Wagner HN; Conti PS
    Cancer; 1991 Feb; 67(4 Suppl):1121-8. PubMed ID: 1991270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular tracers for the PET and SPECT imaging of disease.
    Pimlott SL; Sutherland A
    Chem Soc Rev; 2011 Jan; 40(1):149-62. PubMed ID: 20818455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical imaging in anti-atherosclerosis drug development.
    Ehlgen A; Bylock A; Kreuzer J; Koslowski M; Gantner F; Niessen HG
    Drug Discov Today; 2015 Nov; 20(11):1317-27. PubMed ID: 26151479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Imaging of Pancreatic Cancer with Antibodies.
    England CG; Hernandez R; Eddine SB; Cai W
    Mol Pharm; 2016 Jan; 13(1):8-24. PubMed ID: 26620581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Options for visualizing metastatic disease in the living body.
    Helms MW; Brandt BH; Contag CH
    Contrib Microbiol; 2006; 13():209-231. PubMed ID: 16627968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging cancer using single photon techniques.
    Buscombe JR; Bombardieri E
    Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):121-31. PubMed ID: 16010250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined PET/MRI: one step further in multimodality imaging.
    Sauter AW; Wehrl HF; Kolb A; Judenhofer MS; Pichler BJ
    Trends Mol Med; 2010 Nov; 16(11):508-15. PubMed ID: 20851684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.